• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    25.55 Down 1.26(4.70%) Apr 17, 4:00PM EDT
    |After Hours : 25.55 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Prev Close:26.81
    Open:26.51
    Bid:24.03 x 100
    Ask:26.93 x 100
    1y Target Est:41.00
    Beta:1.637
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:25.07 - 26.70
    52wk Range:16.57 - 29.83
    Volume:161,551
    Avg Vol (3m):144,723
    Market Cap:764.99M
    P/E (ttm):N/A
    EPS (ttm):-1.69
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMED

    Comparison

    Symbol% ChgMkt Cap
    OMEDDown 4.70%764.99M
    STMLDown 0.86%209.45M
    VSTMDown 2.20%351.28M

    Key Statistics

    Forward P/E (1 yr):27.47
    P/S (ttm):20.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.41
    Quarterly EPS Est (Mar-15) :-0.38
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, discovers and develops protein therapeutics targeting cancer stem cells (CSCs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback